Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTPcat: Ropivacaine TTP Block in Cardiac Surgery
NCT04916418Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Placebo with Ropivacaine (2 arms). Primary endpoint: Number of patients with satisfactory pain response measured with visual rating scale (VAS) at 72 hours. Started Oct 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04916418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04916418.